Aria Biosystems
Menlo Park
About Aria Biosystems
Aria Biosystems is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics and concentration. Aria utilizes proprietary bio-layer interferometry (BLI) that enables self-calibration and measurement of molecular interactions using simple-to-use and inexpensive instrumentation. The entire analysis can be completed within minutes and does not require labeling of either probe or target. Aria's analytical capabilities provide greater value in applications where existing methods such as HPLC, ELISA and surface plasmon resonance (SPR) have limitations in throughput, performance and cost.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $5.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2004)
- Website: ariabiosystems.com
- Phone: (650) 322-1360
Industries & Categories
Analytics, Biotechnology, Innovation Management, Medical
Canonical: https://fsome.com/organization/aria-biosystems-2151997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.